CVE-2024-44837 — MEDIUM (5.4)

Vulnerability Description

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Deathbreak	Drug	1.0

Related Weaknesses (CWE)

CWE-79

References

https://kaput-raptorex-7c1.notion.site/drug-1-0-DOM-based-cross-site-scripting-fExploitThird Party Advisory

FAQ

What is CVE-2024-44837?

CVE-2024-44837 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user param...

How severe is CVE-2024-44837?

CVE-2024-44837 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2024-44837?

Check the references section above for vendor advisories and patch information. Affected products include: Deathbreak Drug.